-transparent.png){kind=logo}
The present study compares the debrisoquine monooxygenase and the sparteine monooxygenase activities of human liver microsomes. In the presence of 14 competitive inhibitors, apparent inhibition constants (Ki) as determined by these two activities ranged over four orders of magnitude with a correlation coefficient 0.99. These in vitro results represent the strongest evidence to date that the debrisoquine monooxygenase and the sparteine monooxygenase are identical and involve a single isozyme of cytochrome P-450.
Related Publications
T Inaba, and
M Nakano, and
S V Otton, and
W A Mahon, and
W Kalow
January 1985,
Drug metabolism and disposition: the biological fate of chemicals,
T Inaba, and
M Nakano, and
S V Otton, and
W A Mahon, and
W Kalow
April 1987,
British journal of clinical pharmacology,
T Inaba, and
M Nakano, and
S V Otton, and
W A Mahon, and
W Kalow
July 1987,
Biochemical and biophysical research communications,
T Inaba, and
M Nakano, and
S V Otton, and
W A Mahon, and
W Kalow
October 1982,
Biochemical pharmacology,
T Inaba, and
M Nakano, and
S V Otton, and
W A Mahon, and
W Kalow
October 1981,
Archives of biochemistry and biophysics,
T Inaba, and
M Nakano, and
S V Otton, and
W A Mahon, and
W Kalow
September 1986,
Biochemical pharmacology,
T Inaba, and
M Nakano, and
S V Otton, and
W A Mahon, and
W Kalow
March 1986,
British journal of clinical pharmacology,
T Inaba, and
M Nakano, and
S V Otton, and
W A Mahon, and
W Kalow
May 1988,
Pharmacology & toxicology,
T Inaba, and
M Nakano, and
S V Otton, and
W A Mahon, and
W Kalow
March 1979,
Molecular pharmacology,
T Inaba, and
M Nakano, and
S V Otton, and
W A Mahon, and
W Kalow
April 1988,
Biochemical and biophysical research communications,
